Details of the Drug Formulaction

General Information of Drug Formulation (ID: F14818)

• Formulation Name: Nadolol 20 mg tablet
• Company: Avera McKennan Hospital; BluePoint Laboratories; Sandoz

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Nadolol	(DMW6GVL)	Angina pectoris	BA40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Water	(E00035)	962	Solvent